Author | Saby George, MD

Articles

Continuing Nivolumab After Progression Improves Survival in RCC

June 23, 2016

In this video we discuss the continuation of nivolumab after tumor progression in patients with advanced renal cell carcinoma in the CheckMate 025 trial.